Linda Palczuk - Jan 24, 2025 Form 4 Insider Report for AVADEL PHARMACEUTICALS PLC (AVDL)

Role
Director
Signature
/s/ Jerad G. Seurer, as attorney-in-fact
Stock symbol
AVDL
Transactions as of
Jan 24, 2025
Transactions value $
$0
Form type
4
Date filed
1/28/2025, 04:22 PM
Previous filing
Jan 22, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVDL Stock Option (Right to Buy) Gift $0 -25K -100% $0.00 0 Jan 24, 2025 Ordinary Shares 25K $10.93 Direct F1
holding AVDL Stock Option (Right to Buy) 25K Jan 24, 2025 Ordinary Shares 25K $10.93 By Trust F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options become exercisable in three equal annual installments on each of the first three anniversaries following the 12/17/2024 grant date, subject to the Reporting Person's continued service at each such vesting date.
F2 On January 24, 2025, the Reporting Person transferred 25,000 options to a revocable trust of which the Reporting Person is trustee.